Cellyan Biotechnology Ratios (2024-2025) | HKPD

Ratios Mar2024 Sep2024 Mar2025 Sep2025
Efficiency
Assets Average (Quarter) 9.41M9.79M9.53M
Equity Average (Quarter) 4.80M5.17M5.07M
Invested Capital (Quarter) 4.43M5.36M5.36M5.50M
Leverage & Solvency
Debt to Equity (Quarter) 0.310.190.380.07
Debt Ratio (Quarter) 0.150.100.200.04
Equity Ratio (Quarter) 0.490.530.530.53
Valuation
Enterprise Value (Quarter) -0.63M-0.37M-3.01M-2.48M